Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 2025 Q3

NCS Multistage Holdings, Inc. (NASDAQ: NCSM) has shown robust performance in its third quarter of 2025, as revealed in the latest coverage by Stonegate Capital Partners. The company reported total revenues of $46.5 million, marking a 6.0% increase year-over-year, which reflects its ability to outperform broader industry trends. The growth is attributed to a significant rise in both U.S. and international product sales, particularly in fracturing systems and wellbore construction projects in the North Sea and the Middle East, despite facing a downturn in Canadian product sales due to lower rig counts.

Notably, international revenues soared approximately 38.0% year-over-year, while U.S. revenues recorded an impressive growth of about 36.0% during the same timeframe. The company also experienced a sequential growth of 32% in Canada as the effects of the spring break-up period subsided. Adjusted gross margins for the quarter were reported at 41.7%, a slight decline from 42.1% in Q3 2024.

Looking ahead, NCSM anticipates modest revenue and margin growth for the remainder of the fiscal year 2025, driven by the resilience of its core product lines and the integration of its recent acquisition, ResMetrics, which contributed around $2 million to U.S. tracer diagnostics in the third quarter. The company also reported an adjusted EBITDA of $7.0 million, with diluted earnings per share (EPS) reaching $1.37.

Stonegate continues to support NCSM's positive trajectory, citing strong performance and market adaptability as key factors for future growth.

NCS Multistage Holdings, Inc. (NASDAQ: NCSM) recently provided a promising update for investors with its 3Q25 results, indicating a positive trend in revenue growth despite some regional challenges. Reporting total revenues of $46.5 million, the company demonstrated a solid 6.0% year-over-year increase, surpassing many industry expectations. Notably, the substantial contributions from U.S. and international markets—particularly in fracturing systems and wellbore construction—signal strong operational performance.

The increase in international revenue by approximately 38% year-over-year, alongside a 36% rise in U.S. revenue, highlights a robust demand for NCSM’s offerings. This growth occurred despite a downturn in Canadian sales, attributed to lower rig counts. However, the sequential growth of 32% in Canada as spring break-up impacts waned suggests that the Canadian market may rebound in future quarters.

Investors should also take note of the adjusted gross margins, which slightly declined to 41.7% from 42.1%, hinting at potential cost pressures. Despite this, the resilience of the core product lines and the successful integration of the ResMetrics acquisition—adding approximately $2 million to U.S. tracer diagnostics in Q3—bodes well for long-term profitability.

Moving forward, maintaining awareness of market dynamics is critical. The forecast for modest revenue and margin growth throughout FY25 seems optimistic, given current trends. With earnings per share (EPS) at $1.37 and adjusted EBITDA at $7 million, NCSM appears positioned for sustainable growth.

For investors considering entry or holding shares in NCSM, the overall outlook stays positive. Strategic investments in innovation and market expansion, particularly in thriving international markets, underline NCSM's potential for future upside in value. As always, vigilance regarding market conditions and operational execution will be essential in evaluating potential risks and rewards.